(Q44638649)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

1 reference

1 reference

chronic lymphocytic leukemia

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Rami Hayun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Alain Berrebi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Lev Shvidel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Lucette Bassous

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Benjamin Sredni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Uri Nir

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

625-632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

Evolving view of the in-vivo kinetics of chronic lymphocytic leukemia B cells

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Preclinical assessment of curcumin as a potential therapy for B-CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

"Spicing up" of the immune system by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Recent advances in targeted therapy for non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Biological effects of curcumin and its role in cancer chemoprevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Detection of apoptosis of immature CD4+8+ thymocytes by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Valproic acid sensitizes chronic lymphocytic leukemia cells to apoptosis and restores the balance between pro- and antiapoptotic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Fatal Epstein-Barr virus-associated lymphoproliferative disorder following treatment with a novel mTOR inhibitor for relapsed chronic lymphocytic leukemia leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

Mammalian target of rapamycin (mTOR) inhibition in chronic lymphocytic B-cell leukemia: a new therapeutic option

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902789181

10.1080/10428190902789181

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19373661%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference